Harmony Biosciences board appoints Peter Anastasiou as CEO
Harmony Biosciences appointed Peter Anastasiou as president and chief executive officer, Dow Jones Newswires reported. No further details were provided.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
The board of Harmony Biosciences appointed Peter Anastasiou as president and chief executive officer, Dow Jones Newswires reported.
The report did not provide additional details on when Anastasiou will take the roles or why the board made the decision.
why it matters
A leadership change may matter to investors assessing Harmony Biosciences’ future strategic direction and corporate governance.
instruments
sources
- Harmony Biosciences Board Names Peter Anastasiou to Become Pres, Chief Executive Officer >HRMY — Dow Jones Newswires, 12 October 2026 at 11:01 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗